MBMikael Begtrup

Mikael Begtrup

*This is an algorithmically generated author record based on publicly available information.

Mikael Begtrup has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Jesper Langgaard Kristensen

    Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark

    2 shared publications
  • Kåre Søndergaard

    The Danish University of Pharmaceutical Sciences, Department of Medicinal Chemistry, Universitetsparken 2, DK-2100, Copenhagen, Denmark

    2 shared publications
  • Bryan L. Roth

    Department of Biochemistry, SOM-W444, Case Western Reserve University, 2109 Adelbert Rd., Cleveland, OH, USA

    1 shared publication
  • Gitte Moos Knudsen

    Neurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark

    1 shared publication
  • Mikael Palner

    Clinical Physiology and Nuclear Medicine, Department of Clinical Research, University of Southern Denmark, Odense, Denmark

    1 shared publication
  • Nic Gillings

    University Hospital Rigshospitalet, PET and Cyclotron Unit, Blegdamsvej 9, 2100 Copenhagen, Denmark

    1 shared publication

Latest Publications

  • Synthesis and binding studies of 2-arylapomorphines

    by Kåre Søndergaard, Jesper Langgaard Kristensen, Mikael Palner, Nic Gillings, Gitte Moos Knudsen, Bryan L. Roth, Mikael Begtrup

    From codeine, four different 2-aryl substituted apomorphines were synthesised in 6 steps each. Oxidation of codeine with IBX followed by acid catalysed rearrangement gave morphothebaine, which was selectively triflylated at the 2-position and subsequently O-acetylated at the 11-position. The resulting triflate was coupled in a Suzuki–Miyaura type reaction with a series of 4-substituted arylboronic esters which, after deprotection, gave the desired 2-aryl apomorphines. The analogues were tested for affinity towards a range of dopaminergic, serotonergic and adrenergic receptors. 2-(4-Hydroxyphenyl)-apomorphine exhibited high affinity for the dopamine D2 receptor. A putative ligand–receptor interaction was put forward.


  • Synthesis of (R)‐(–)‐2‐Fluoronorapomorphine — A Precursor for the Synthesis of (R)‐(–)‐2‐Fluoro‐N‐[11C]propylnorapomorphine for Evaluation as a Dopamine D2 Agonist Ligand for PET Investigations

    by Kåre Søndergaard, Jesper Langgaard Kristensen, Nic Gillings, Mikael Begtrup

    2‐Fluoronorapomorphine, the PET labelling precursor to 2‐fluoro‐N‐[11C]propylnorapomorphine, was prepared in 13 steps from codeine in a total yield of 10 %. Codeine was converted in four steps into N‐benzylnorcodeine which was oxidised by using the Swern protocol. Subsequent acid‐catalysed rearrangement afforded N‐benzylnormorphothebaine which was selectively triflylated at the 2‐position and pivaloylated at the 11‐position. The triflate underwent palladium‐catalysed amination with benzophenone imine. Amination conditions required sequential base addition to give substantial conversion of the triflate to the corresponding N‐substituted benzophenone imine. After acidic hydrolysis the resulting aniline was transformed into the 2‐fluoro compound via the Balz–Schiemann reaction. Hydrogenolysis of the N‐benzyl group followed by deprotection of the catechol moiety using BBr3 provided 2‐fluoronorapomorphine. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2005)